Reckitt Benckiser in talks to acquire Mead Johnson for US$16.7b
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
RECKITT Benckiser Group Plc is in talks to buy baby formula maker Mead Johnson Nutrition Co for about US$16.7 billion, the latest push by the Durex condom maker to build on its faster growing consumer-health business and bolster its presence in Asian markets.
The companies are discussing an offer of US$90 a share in cash, Reckitt Benckiser said late on Wednesday. That's 29 per cent higher than Mead Johnson's closing stock price. Reckitt Benckiser, based in Slough, England, would finance its biggest-ever deal with cash and debt. Mead Johnson confirmed the discussions in a separate statement, and both companies said there is no certainty that any transaction will ultimately be agreed on.
Share with us your feedback on BT's products and services
